Englisch
Französisch
Deutsch
Italienisch
Spanisch
Tschechisch
Niederländisch
Nootropil (Piracetam)
* Nur zur Veranschaulichung
Nootropil (Piracetam)
Kurze Beschreibung
Wirkstoff: Piracetam
Anwendungsgebiet: Nootropil verkürzt die Dauer des vestibulären Nystagmus
Verfügbare Dosierungen: 800mg, 1200mg
Nootropil (Piracetam) 1200 mg 30 Tabl. 30 Tabl.
1,465.04 NOK
Nootropil (Piracetam) 1200 mg 60 Tabl. 60 Tabl.
2,064.90 NOK
Nootropil (Piracetam) 1200 mg 90 Tabl. 90 Tabl.
2,676.30 NOK
Nootropil (Piracetam) 1200 mg 120 Tabl. 120 Tabl.
3,276.16 NOK
Nootropil (Piracetam) 1200 mg 180 Tabl. 180 Tabl.
4,475.87 NOK
Nootropil (Piracetam) 1200 mg 240 Tabl. 240 Tabl.
6,540.78 NOK
Nootropil (Piracetam) 1200 mg 270 Tabl. 270 Tabl.
7,140.64 NOK
Nootropil (Piracetam) 1200 mg 360 Tabl. 360 Tabl.
8,951.75 NOK
Nootropil (Piracetam) 800 mg 30 Tabl. 30 Tabl.
1,257.40 NOK
Nootropil (Piracetam) 800 mg 60 Tabl. 60 Tabl.
1,776.51 NOK
Nootropil (Piracetam) 800 mg 90 Tabl. 90 Tabl.
2,295.62 NOK
Nootropil (Piracetam) 800 mg 120 Tabl. 120 Tabl.
2,803.19 NOK
Nootropil (Piracetam) 800 mg 180 Tabl. 180 Tabl.
3,841.41 NOK
Nootropil (Piracetam) 800 mg 240 Tabl. 240 Tabl.
5,606.38 NOK
Nootropil (Piracetam) 800 mg 270 Tabl. 270 Tabl.
6,125.49 NOK
Nootropil (Piracetam) 800 mg 360 Tabl. 360 Tabl.
7,671.28 NOK
in den Warenkorb gelegt
Fügen Sie Artikel im Wert von hinzu und erhalten kostenlosen Versand.
-
Versandca 5-9 TageGarantierte Lieferzeit 16 Werktage
-
Zahlung
Nootropil (Piracetam)
The dosage regime shows important interindividual variability, requiring an individualised dose finding approach. A reasonable protocol would be to introduce piracetam at a dosage of 7.2 g/day, increasing by 4.8 g/day every 3 to 4 days up to a maximum of 20g/day, given in either 2 or 3 divided doses while keeping other antimyoclonic drugs unchanged at their optimal dosage. If possible, depending on clinical benefit, an attempt should be made to subsequently reduce the dosage of other antimyoclonic drugs.
The side effects reported in connection with Nootropil include nervousness, agitation, irritability, anxiety and sleep disturbances. The incidence of these during clinical trials was 5% or less and they were more often noted in the older patients taking more than 2.4 g daily. In the majority of cases a dose reduction sufficed to make these symptoms disappeared. Some patients may complain of fatigue or drowsiness. Gastro-intestinal problems such as nausea, vomiting, diarrhoea and stomachache have also been reported, but their Incidence during clinical trials was 2% or less. Other symptoms, such as vertigo, headaches, trembling and sexual stimulation have occasionally been reported.
Take the medicine as prescribed by your doctor.
Store this medicine at room temperature in a tightly-closed container, away from heat and light.